Kenvue CEO Discusses Growth Outlook After J&J Unit Jumps 20% in Market Debut

Johnson & Johnson's consumer-health unit Kenvue made its debut on the New York Stock Exchange and jumped about 20% on Thursday. Thibaut Mongon, CEO of Kenvue, joined Cheddar News to discuss business growth goals and what lies ahead for its well-known pipeline of products, including Band-Aid, Neutrogena, Tylenol, among others.

More In Business

First to Fly Wins? Why the eVTOL Race Just Turned Contentious

FAA certification nears, but Archer’s patent fight with Vertical signals rising pressure in the electric air taxi sector.

How Iran Tensions Could Hit U.S. Gas Prices

Oil nears $79 as Iran tensions disrupt Hormuz and LNG halts. Timothy Cama, Politics & Influence Reporter at POLITICO’s E&E News, explains.

Big Business This Week: Will tariff policy ever stabilize enough so that big business can plan?

“Whatever you had planned, whatever you thought you knew is changed,” said one analyst this week following the overhaul of tariff policy.

Netflix Walks Away! Paramount in Lead to Scoop up Warner Bros. Discovery

Netflix Walks Away! Paramount in Lead to Scoop up Warner Bros. Discovery

Heart-Pounding Finish: Why This Beast Games Finale Changes Everything

Sean Klitzner, showrunner and co-creator of Beast Games, previews the Feb. 25 finale packed with bigger stunts, wild twists, and the highest stakes yet.

Inside the Explosive Case Accusing Social Media of Harming Kids

Maria Curi, tech policy reporter at Axios, breaks down Meta’s landmark trial as Zuckerberg testifies in a case that could reshape tech accountability.

Load More